The effect of vedolizumab (anti-α4β7-integrin) therapy on colonic mucosal gene expression in patients with ulcerative colitis (UC)

ABSTRACT: Microarrays were used to investigate the the effect of vedolizumab (VDZ) therapy on colonic mucosal gene expression in UC patients and compared the changes to those observed with infliximab (IFX) therapy.

ORGANISM(S): Homo sapiens

PROVIDER: GSE73661 | GEO | 2016/10/11

SECONDARY ACCESSION(S): PRJNA297578

REPOSITORIES: GEO